Makoto Kakutani

1.4k total citations
35 papers, 1.2k citations indexed

About

Makoto Kakutani is a scholar working on Surgery, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Makoto Kakutani has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Physiology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Makoto Kakutani's work include Pancreatic function and diabetes (10 papers), Atherosclerosis and Cardiovascular Diseases (7 papers) and Adipose Tissue and Metabolism (7 papers). Makoto Kakutani is often cited by papers focused on Pancreatic function and diabetes (10 papers), Atherosclerosis and Cardiovascular Diseases (7 papers) and Adipose Tissue and Metabolism (7 papers). Makoto Kakutani collaborates with scholars based in Japan, United States and Switzerland. Makoto Kakutani's co-authors include Tatsuya Sawamura, Τοmoh Masaki, Shuh Narumiya, Mingyi Chen, Takeshi Ohta, Makiko Ueda, Takahiko Naruko, Yukihito Ishii, Takahiro Hata and Noriaki Kume and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Biochemical and Biophysical Research Communications.

In The Last Decade

Makoto Kakutani

35 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Makoto Kakutani Japan 17 502 317 247 218 141 35 1.2k
Hana Levkovitz Israel 16 555 1.1× 221 0.7× 372 1.5× 100 0.5× 97 0.7× 24 1.2k
A. Rigoni Italy 14 586 1.2× 199 0.6× 337 1.4× 190 0.9× 164 1.2× 19 1.3k
Jitske de Vries-van der Weij Netherlands 10 298 0.6× 348 1.1× 326 1.3× 159 0.7× 110 0.8× 12 1.0k
Constanze Bergt United States 11 582 1.2× 364 1.1× 446 1.8× 290 1.3× 348 2.5× 13 1.3k
Susanne Zadelaar Netherlands 8 553 1.1× 402 1.3× 577 2.3× 175 0.8× 188 1.3× 9 1.7k
Steven S. Mundt United States 15 353 0.7× 398 1.3× 375 1.5× 432 2.0× 173 1.2× 23 1.4k
Sona Mitra United States 15 472 0.9× 184 0.6× 337 1.4× 68 0.3× 95 0.7× 27 1.1k
Greg P. Hough United States 7 296 0.6× 564 1.8× 258 1.0× 486 2.2× 99 0.7× 7 1.4k
José W.A. van der Hoorn Netherlands 21 365 0.7× 662 2.1× 357 1.4× 264 1.2× 139 1.0× 27 1.5k
Timo P. Hiltunen Finland 19 255 0.5× 276 0.9× 507 2.1× 338 1.6× 189 1.3× 49 1.4k

Countries citing papers authored by Makoto Kakutani

Since Specialization
Citations

This map shows the geographic impact of Makoto Kakutani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Kakutani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Kakutani more than expected).

Fields of papers citing papers by Makoto Kakutani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makoto Kakutani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Kakutani. The network helps show where Makoto Kakutani may publish in the future.

Co-authorship network of co-authors of Makoto Kakutani

This figure shows the co-authorship network connecting the top 25 collaborators of Makoto Kakutani. A scholar is included among the top collaborators of Makoto Kakutani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makoto Kakutani. Makoto Kakutani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohta, Takeshi, et al.. (2016). Intrajejunal infusion of 2-monoacylglycerol reduced food intake without inducing diarrhea in rats. Journal of Pharmacological Sciences. 130(2). 136–138. 3 indexed citations
2.
Ohta, Takeshi, et al.. (2015). JTP-103237, a monoacylglycerol acyltransferase inhibitor, prevents fatty liver and suppresses both triglyceride synthesis and de novo lipogenesis. Journal of Pharmacological Sciences. 128(3). 150–157. 10 indexed citations
4.
Kawai, Takashi, Naoto Ogawa, Tomohiko Sasase, et al.. (2015). JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models. Journal of Pharmacological Sciences. 129(3). 169–176. 10 indexed citations
5.
Ishii, Yukihito, Akio Kobayashi, Takeshi Ohta, et al.. (2015). JTT-553, a novel Acyl CoA:diacylglycerol acyltransferase (DGAT) 1 inhibitor, improves glucose metabolism in diet-induced obesity and genetic T2DM mice. Journal of Pharmacological Sciences. 129(1). 51–58. 17 indexed citations
6.
Hata, Takahiro, et al.. (2014). JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Reduces Food Preference for Fat. Journal of Diabetes Research. 2014. 1–7. 5 indexed citations
7.
Kakutani, Makoto, et al.. (2014). Mechanism of action of hypoglycemic effects of an intestine-specific inhibitor of microsomal triglyceride transfer protein (MTP) in obese rats. Journal of Pharmacological Sciences. 127(1). 103–108. 6 indexed citations
8.
Hata, Takahiro, Takashi Kawai, Yoshiharu Ishii, et al.. (2011). JTT‐130, a novel intestine‐specific inhibitor of microsomal triglyceride transfer protein, ameliorates impaired glucose and lipid metabolism in Zucker diabetic fatty rats. Diabetes Obesity and Metabolism. 13(7). 629–638. 17 indexed citations
10.
Niesor, Eric J., Christine Magg, Naoto Ogawa, et al.. (2010). Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport. Journal of Lipid Research. 51(12). 3443–3454. 128 indexed citations
11.
Maugeais, Cyrille, Christine Magg, Gregor Dernick, et al.. (2009). Abstract 1092: Dalcetrapib Binds to and Changes the Conformation of CETP in a Unique Manner (Differing to That Observed With Torcetrapib). Circulation. 120(3). 229–38. 3 indexed citations
12.
Niesor, Eric J., Hiroshi Okamoto, Cyrille Maugeais, et al.. (2009). Abstract 1271: The Effects of Dalcetrapib on Macrophage Reverse Cholesterol Transport in a Rodent Model. Circulation. 120. 3 indexed citations
13.
Ogawa, Nobuya, Hideki Yamaguchi, Takuya Shimbara, et al.. (2008). The vagal afferent pathway does not play a major role in the induction of satiety by intestinal fatty acid in rats. Neuroscience Letters. 433(1). 38–42. 12 indexed citations
14.
Ito, Makoto, Yuji Ishida, Makoto Kakutani, et al.. (2006). JTP‐426467 acts as a selective antagonist for peroxisome proliferator‐activated receptor γ in vitro and in vivo. Diabetes Obesity and Metabolism. 8(5). 508–516. 49 indexed citations
15.
Kakutani, Makoto, et al.. (2005). Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovascular Research. 69(1). 263–271. 59 indexed citations
16.
Kakutani, Makoto, Makiko Ueda, Takahiko Naruko, Τοmoh Masaki, & Tatsuya Sawamura. (2001). Accumulation of LOX-1 Ligand in Plasma and Atherosclerotic Lesions of Watanabe Heritable Hyperlipidemic Rabbits: Identification by a Novel Enzyme Immunoassay. Biochemical and Biophysical Research Communications. 282(1). 180–185. 31 indexed citations
17.
Kakutani, Makoto, Τοmoh Masaki, & Tatsuya Sawamura. (2000). A platelet–endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proceedings of the National Academy of Sciences. 97(1). 360–364. 142 indexed citations
18.
Chen, Mingyi, Makoto Kakutani, Manabu Minami, et al.. (2000). Increased Expression of Lectinlike Oxidized Low Density Lipoprotein Receptor-1 in Initial Atherosclerotic Lesions of Watanabe Heritable Hyperlipidemic Rabbits. Arteriosclerosis Thrombosis and Vascular Biology. 20(4). 1107–1115. 162 indexed citations
19.
Hoshikawa, Hajime, et al.. (1998). High Affinity Binding of Oxidized LDL to Mouse Lectin-like Oxidized LDL Receptor (LOX-1). Biochemical and Biophysical Research Communications. 245(3). 841–846. 24 indexed citations
20.
Kakutani, Makoto, Makoto Murakami, Hitoshi Okamoto, Ichiro Kudo, & Keizo Inoue. (1994). Role of type II phospholipase A2 in the inflammatory process of carrageenan‐induced pleurisy in rats. FEBS Letters. 339(1-2). 76–78. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026